<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Iran J Parasitol</span><span class="iso-abbrev" title="iso-abbrev">Iran J Parasitol</span><span class="publisher-id" title="publisher-id">IJPA</span><span class="pmc" title="pmc">IJPA</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Iranian Journal of Parasitology</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1735-7020</span><span class="issn-epub" tagx="issn" title="issn-epub">2008-238X</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Tehran University of Medical Sciences</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7548454">7548454</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.18502/ijpa.v15i3.4201">10.18502/ijpa.v15i3.4201</a></span><span class="publisher-id" title="publisher-id">IJPA-15-364</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Original Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Anthelmintic Efficacy of Supramolecular Complex of Praziquantel Obtained by Mechanochemical Technology</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">ARKHIPOV</span><span class="given-names" tagx="given-names" title="given-names">Ivan</span></span><a href="#AFF1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KHALIKOV</span><span class="given-names" tagx="given-names" title="given-names">Salavat</span></span><a href="#AFF2"><sup>2</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">DUSHKIN</span><span class="given-names" tagx="given-names" title="given-names">Alexander</span></span><a href="#AFF3"><sup>3</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SADOV</span><span class="given-names" tagx="given-names" title="given-names">Konstantin</span></span><a href="#AFF1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">METELEVA</span><span class="given-names" tagx="given-names" title="given-names">Elizaveta</span></span><a href="#AFF3"><sup>3</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">ARISOV</span><span class="given-names" tagx="given-names" title="given-names">Michael</span></span><a href="#AFF1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">VARLAMOVA</span><span class="given-names" tagx="given-names" title="given-names">Anastasiya</span></span><a href="#AFF1"><sup>1</sup></a><a href="#C1"><sup>*</sup></a></span><span class="citation_author_institution" id="AFF1">[1.], </span><span class="citation_author_institution" id="AFF2">[2.], </span><span class="citation_author_institution" id="AFF3">[3.], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">*</span><b>Correspondence Email:</b><span class="email" tagx="email" title="email">arsphoeb@mail.ru</span></div> </div><span class="pub-date-ppub" title="pub-date-ppub">ppub: <span>2020</span></span><span class="volume" tagx="volume" title="volume">15</span><span class="issue" tagx="issue" title="issue">3</span><span class="fpage" tagx="fpage" title="fpage">364</span><span class="lpage" tagx="lpage" title="lpage">373</span><span class="history" title="history"><span class="received" title="received">received: 2019-10-19</span><span class="accepted" title="accepted">accepted: 2020-1-11</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="background:" title="sec"> <div class="title" tagx="title" title="title">
Background:</div> <p>A supramolecular complex of praziquantel (PZQ) with disodium salt of glycyrrhizic acid (Na<sub>2</sub>GA) was obtained by mechanochemical technology to increase solubility, absorption rate and hence bioavailability of the drug and reduction its therapeutic doses. The aim of our study was evaluation of anthelmintic efficacy of supramolecular complex of PZQ.</p> </div> <div class="methods:" title="sec"> <div class="title" tagx="title" title="title">
Methods:</div> <p>Different samples of PZQ with Na<sub>2</sub>GA were obtained by mechanochemical processing and examined for some physico-chemical properties. The anthelmintic activity of the most perspective samples was studied on the laboratory model of <i>Hymenolepis nana</i> infection of mice and <i>Moniezia expansa</i> infection of sheep by the results of helminthological necropsy of the small intestines (the controlled test).</p> </div> <div class="results:" title="sec"> <div class="title" tagx="title" title="title">
Results:</div> <p>A high efficacy (&amp;gt; 98%) of supramolecular complex of PZQ with Na<sub>2</sub>GA (1/10) was shown at doses of 3; 2 and 1 mg/kg of body weight at single oral administration against <i>H. nana</i> in mice and <i>M. expansa</i> in sheep. While the basic PZQ had 27.19% and 36.64% efficacy respectively at the dose of 1 mg/kg. The PZQ:Na<sub>2</sub>GA 1/10 physical mixture (without mechanochemical processing) revealed no anthelmintic efficacy.</p> </div> <div class="conclusion:" title="sec"> <div class="title" tagx="title" title="title">
Conclusion:</div> <p>Joint mechanochemical treatment the PZQ substance and Na<sub>2</sub>GA led to increased solubility, reduction of particle sizes, amorphization of substance, incorporating it with micelles of glycyrrhizic acid and high anthelmintic efficacy in reduced dose. The supramolecular complex of praziquantel was found to be a perspective anthelminthic with enhanced pharmacological activity that needs further research.</p> </div> </div> <div class="kwd-group"> <div class="kwd" title="kwd">
Efficacy</div> <div class="kwd" title="kwd">
Praziquantel</div> <div class="kwd" title="kwd">
Supramolecular complex</div> <div class="kwd" title="kwd">
Mechanochemistry</div> <div class="kwd" title="kwd">
Disodium salt of glycyrrhizic acid</div> </div> </div> </div> <div class="body" title="body"> <div class="intro" title="intro"> <div class="title" tagx="title" title="title">
Introduction</div> <p>Praziquantel (PZQ) is the main drug for treatment of cestodosis of animals and humans (<a href="#B1">1</a>–<a href="#B3">3</a>). However, high doses of PZQ (50–100 mg/kg) are required to treat larval cestodosis of animals that restrict its practical application (<a href="#B4">4</a>, <a href="#B5">5</a>). The high cost of the drug, as well as its high consumption for treatment of large animals (cattle, horses), restrain its use. In this regard, there was an interest in reducing the dose of the drug by increasing its solubility, absorbability and efficacy using mechanochemical technology to produce solid dispersions of anthelmintics with hydrophilic carriers - plant and synthetic polymers, as well as with lipophilic-hydrophobic substances as drug delivery systems.</p> <p>As a carrier, we have used disodium salt of glycyrrhizic acid (Na<sub>2</sub>GA). An important feature of glycyrrhizic acid (GA) solutions is the possibility of including lipophilic low-soluble molecules in the structure of micelles or other self-associates, that significantly increase the overall concentration of their molecules in a free and bound form in aqueous solutions (<a href="#B6">6</a>, <a href="#B7">7</a>). Nevertheless, the use of pure GA as a carrier of drug molecules has a disadvantage in the phenomenon of gelling of its concentrated solutions. The use of its disubstituted salts of alkali metal makes it possible to eliminate this phenomenon.</p> <p>Thus, the aim of our study was to obtain a supramolecular complex of PZQ with Na<sub>2</sub>GA by mechanochemical technology and to study its physicochemical features and anthelmintic activity in comparison with the substance of original PZQ (without Na<sub>2</sub>GA) and with the physical mixture of PZQ:Na<sub>2</sub>GA 1/10 without mechanochemical processing.</p> </div> <div class="materials_methods" title="materials|methods"> <div class="title" tagx="title" title="title">
Materials and Methods</div> <p>The research was blinded, randomized and placebo-controlled. Studies were carried out according to the adopted rules (<a href="#B8">8</a>–<a href="#B10">10</a>). Council on Ethics at the Ministry of Health of Russia approved the trials. Clinical trials governmental registration protocol № 615–110; 25.09.2017.</p> <p>Solid phase was conducted in one step of mechanochemical treatment of PZQ with Na<sub>2</sub>GA in a Ball Drum Mill LE-101 (Hungary) in a weight ratio of 1:5, 1:10 and 1:20 (<a href="#B11">11</a>, <a href="#B12">12</a>).The drum was set on rolls and the mixture was processed for 4 h at a speed of 156 revolutions per minute; acceleration of grinding media - 1g with steel balls with diameter of 22 mm. Other samples were obtained by mechanochemical technology without an auxiliary substance - Na<sub>2</sub>GA by processing in planetary mill AGO-2 (Novosibirsk, Russia). Processing mode: acceleration of grinding media – 20 g and 40 g, weight of the material – 2.5 g, drum capacity – 50 mL, grinding media-steel balls (diameter 6 mm, 75.0 g load), processing time – 5 min (<a href="#B11">11</a>, <a href="#B12">12</a>).</p> <div class="characterization" title="sec"> <div class="title" tagx="title" title="title">
Characterization</div> <p>The solubility of samples was evaluated by dissolution (approx. 0.55 g) in distilled water (10 ml) in shaker-incubator at 37 °C and 200 rpm for three hours. The concentration of drug substances in solutions was analyzed by HPLC on Agilent 1200 (Agilent technologies, Santa Clara, USA) with a Zorbax Eclipse XDB-C18 column (50 × 4.6 mm) and diode-array detector; eluent: acetonitrile/acetate buffer pH 3.4 (1:2); detection on wavelength: 210 nm. The thermal analysis was conducted by Differential Scanning Calorimeter-550 (Instrument Scientific Specialists Inc., Twin Lakes, USA) in argon atmosphere (20–250 °C; rate of heating: 10 °C/min). The morphology of tested substances was studied by Hitachi microscope TM-1000 (Hitachi High-Technologies Corp., Tokyo, Japan). Diffractometer DRON-4 was used for X-ray analysis with CuK<sub>α</sub>-radiation at 2 deg/min (l=1000) in the angle range of 4–65 degrees (Bourevestnik Inc., St. Petersburg, Russia). The method of Higuchi and Connors was used for phase solubility studies (<a href="#B13">13</a>). After equilibrium of dissolved samples was reached, the suspensions were centrifuged (12000 rpm; 10 min). Super-natants were filtered and examined for PZQ concentration by HPLC. The total molar concentration of Na<sub>2</sub>GA (Х-axis) and the total molar concentration of PZQ (Y-axis) were used for construction of the phase solubility diagram. In vitro parallel artificial membrane permeability assay (PAMPA) experiment was conducted in 12-well filter plates (polycarbonate membrane, 12 mm diameter, 0.4 μm pore size, 1.12 cm<sup>2</sup> area, Corning Incorporated) to predict passive intestinal absorption (<a href="#B14">14</a>). The artificial membrane was saturated by pipetting 60 μL of the 5% hexadecane in hexane solution to each wells of the donor plate. After hexane evaporation about 1.5 mL of distilled water was added to each wells of the acceptor plate. The hexadecane treated donor plate was then placed on top of the 12-well acceptor plate. Then, 0.5 mL of PZQ or its compositions solutions in distilled water were added to each well of the donor plate, and the plate was placed in shaker-incubator for 2.5 h (37 °C, 200 rpm). Samples (1 mL) were collected from the acceptor plate at appropriate time points (0.25h, 0.5 h, 0.75h, 1.0 h, 1.25h, 1.5 h, 1.75h, 2 h, 2.25h, 2.5h) and were analyzed by HPLC, and the same volume of distilled water was replenished. All these methods have been described previously (<a href="#B11">11</a>, <a href="#B12">12</a>, <a href="#B15">15</a>–<a href="#B17">17</a>).</p> </div> <div class="methods" title="methods"> <div class="title" tagx="title" title="title">
Study Animals</div> <div class="h.nanainfectionofmice" title="sec"> <div class="title" tagx="title" title="title">
H. nana infection of mice</div> <p>The study of the efficacy of supramolecular complex of PZQ with Na<sub>2</sub>GA (1:10) against <i>H. nana</i> infection of mice was conducted on 50 inbred white mice BALB/c (Branch Stolbovaya FSBES of NCBMT FMBA of Russia) of both sexes (16–18 g). Mice were quarantined and adapted for 7 days before the experiment. Then animals were divided into polycarbonate cages of 6 animals each in the vivarium with controlled environment of 20–22 °C and humidity of 60–70 %. Mice received rat feed (LLC Laboratorkorm, Moscow, Russia) according to the daily feed rate of the Russian Federation (<a href="#B18">18</a>). Water was provided <i>ad libitum</i> during the study. Animals were randomly selected in groups by the method of random numbers and with the same body weight for the trials.</p> <p>Cestodes of <i>H. nana</i> collected from the previous infection were destroyed in a small volume of tap water by repeatedly sucking into a syringe with a needle-cannula. About 200 infective eggs of <i>H. nana</i> were administered orally to each mouse with a disposable syringe of 1 ml connected to 25 mm needle. After infection - on the 5<sup>th</sup> day after inoculation, the feces were examined daily by the sedimentation method in order to find eggs of <i>H. nana</i> (<a href="#B19">19</a>).</p> </div> <div class="monieziosisofsheep" title="sec"> <div class="title" tagx="title" title="title">
Monieziosis of sheep</div> <p>The anthelmintic activity of supramolecular complex of PZQ was studied in sheep farm of Samara region (LTD Agro resource), where high levels of <i>Moniezia expansa</i> and <i>Moniezia benedeni</i> infection have been registered. Experiments were conducted during the period of maximum infection on 60 young sheep of Stavropol Merino breed weighing from 17 to 32 kg in 2017. Sheep were kept indoors and fed according to the norms and rations of feeding livestock (<a href="#B20">20</a>). Water was provided <i>ad libitum</i> during the experiment. Fecal examinations were made by the standard fecal examination techniques before the study for random distribution of sheep into the experimental groups with the same number of eggs per gram of feces (<a href="#B21">21</a>).</p> </div> <div class="materials" title="materials"> <div class="title" tagx="title" title="title">
Materials</div> <p>PZQ (2-(Cyclohexylcarbonyl)-1,2,3,6,7-11bhexahydro-4<i>H</i>-pyrazino[2,1-<i>a</i>]isoquinolin-4-one), 98.5%, average Mw ~ 312.41 was purchased from Rensin Chemicals Limited (Nanjing, China). Na2GA was purchased from Shaanxi Sciphar Biotechnology Co. LTD (Xian, China). All other chemicals and solvents were of analytical reagent grade.</p> </div> <div class="experimentalgroups" title="sec"> <div class="title" tagx="title" title="title">
Experimental groups</div> <p>One control group and 5 experimental groups of 10 animals were formed randomly on the 13<sup>th</sup> day after infection by the results of feces examination by McMaster method (<a href="#B21">21</a>). The supramolecular complex of PZQ with Na<sub>2</sub>GA was administered intragastrically to the mice of the 1–3 experimental groups with a stainless steel bulb tipped gavage needle in a dosage rate of 3.0; 2.0 and 1.0 mg/kg of active substance. The 4<sup>th</sup> experimental group received basic PZQ at the dose of 1.0 mg/kg of b/w. One percent starch gel was given to the animals of control group. PZQ: Na<sub>2</sub>GA1/10 physical mixture was administered to the animals of the fifth group at the dose 2 mg/kg of active substance. The animals were sacrificed by cervical dislocation on the 4<sup>th</sup> day after drugs administration.</p> <p>Sheep naturally infected with monieziosis were divided into 5 equal groups of 10–12 animals each by the results of feces examination by McMaster technique (<a href="#B21">21</a>). The supramolecular complex of PZQ with Na<sub>2</sub>GA was administered orally to the animals of the first, second and third groups in the form of 10 % powder once at doses of 1.0, 2.0 and 3.0 mg/kg of b/w respectively. Sheep of the 4<sup>th</sup> received a basic drug – PZQ at the dose of 1.0 mg/kg. The animals of the control group received no preparation.</p> </div> <div class="methods" title="methods"> <div class="title" tagx="title" title="title">
Procedures</div> <p>The efficacy of the supramolecular complex of PZQ with Na<sub>2</sub>GA against <i>H. nana</i> infection of mice was evaluated on the 4<sup>th</sup> day after drug administration by the results of helminthological necropsy of mice intestines. Recovered cestodes were counted. The anthelmintic activity was determined by the results of controlled test (<a href="#B22">22</a>). Identification of <i>M. expansa</i> was based on the distinct morphology of helminthes by the results of helminthological necropsy of sheep intestines on the 10<sup>th</sup> day after treatment (<a href="#B23">23</a>).</p> </div> </div> <div class="methods" title="methods"> <div class="title" tagx="title" title="title">
Statistical methods</div> <p>Statistical analysis of data was performed on geometric mean of number of parasites using the parametric <i>t</i>-test to compare differences between treatment groups and control groups for significance at the <i>P</i> ≤ 0.05. Statistical analysis of data was evaluated by SAS/Stat (version №9.4 of the SAS System for Windows) software.</p> </div> </div> <div class="results" title="results"> <div class="title" tagx="title" title="title">
Results</div> <p>The micrographs obtained by electronic scanning microscopy showed that the initial PZQ consists of crystalline elongated particles of 10–20 μm in size and their aggregates up to 500 μm (<a href="#F1">Fig. 1</a> A). The sample of PZQ after processing in a planetary mill for 5 min at 20 g consists of particles mainly with a size of 50– 100 μm (<a href="#F1">Fig. 1B</a>) and the sample after processing for 5 min at 40 g have the aggregates with sizes of 150–200 μm (<a href="#F1">Fig. 1C</a>). Probably, an increase in the size of the aggregates in the latter case is associated with partial melting of the substance and subsequent sticking. The initial Na<sub>2</sub>GA consists of spherical particles with a size of 5–50 μm (<a href="#F1">Fig. 1D</a>). The particles of the initial substances were crushed to poly-disperse powder consisting of particles with an average size of 5–20 μm and their aggregates after joint mechanochemical processing of PZQ and Na<sub>2</sub>GA (<a href="#F1">Fig. 1E</a>). It can be assumed that PZQ is not a highly crystalline substance based on broadening of the reflexes on the radiographs of original PZQ (<a href="#F2">Fig. 2</a>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 1:</span></a></div>   <p>Electron micrographs of initial substance of praziquntel (A); B. praziquantel processed in AGO-2 mill (20g, 5 min.); C. praziquantel processed in AGO-2 mill (40g, 5 min.); D. Na<sub>2</sub>GA; E. praziquantel/Na<sub>2</sub>GA 1/10 processed in ball drum mill for 4 hours obtained by mechanochemical technology (1/10)</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 2:</span></a></div>   <p>Radiographs of XRA of: 1. praziquantel; 2. praziquantel processed in AGO-2 mill (20g, 5 min.); 3. praziquantel processed in AGO-2 mill (40g, 5 min.); 4. Na<sub>2</sub>GA; 5. physical mixture of praziquantel/Na<sub>2</sub>GA 1/10; 6. praziquantel/Na<sub>2</sub>GA 1/10 processed in ball drum mill for 4 hours</p>   </div> <p>Moreover, its enthalpy of melting is ~ 90 J/g. The type of radiograph does not change significantly, the enthalpy of melting slightly decreases to 85 J/g after processing of PZQ in a planetary mill at 20 g for 5 minutes. The intensity of the reflexes on radiographs decreases after processing of PZQ in a planetary mill at 40 g for 5 min, but complete amorphization does not occur; the enthalpy of melting is 80 J/g. X-ray analysis and thermal analysis of supramolecular complex of PZQ with Na<sub>2</sub>GA indicated a loss of crystallinity of the initial components up to the formation of amorphous phases.</p> <p>At the same time PZQ is distributed in the excess of the amorphous matrix of Na<sub>2</sub>GA, thereby greatly facilitating the formation of the guest-host system (<a href="#F2">Fig. 2</a>–<a href="#F3">3</a>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 3:</span></a></div>   <p>Differential scanning calorimetric thermal curves of: 1. praziquantel; 2. praziquantel processed in AGO-2 mill (20g, 5 min.); 3. praziquantel processed in AGO-2 mill (40g, 5 min.); 4. Na<sub>2</sub>GA; 5. physical mixture of praziquantel/Na<sub>2</sub>GA 1/10; 6. praziquantel/Na<sub>2</sub>GA 1/10 processed in ball drum mill for 4 hours</p>   </div> <p>In all cases, an increase in the solubility of PZQ after mechanochemical processing can be observed, which indicates the formation of intermolecular complexes of PZQ and Na<sub>2</sub>GA. The <a href="#T1">table 1</a> shows the maximum achieved solubility values. The HPLC data also confirmed that no degradation or chemical interactions involving molecules of PZQ have occurred.</p> <div class="table-wrap_UNKNOWN" id="T1" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1:</span> <p>The solubility of PZQ and its compositions</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" valign="top" rowspan="1" colspan="1"><b><i>The composition of the sample, the weight ratio, the production method</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Concentration of PZQ in water, g/l</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>The increase in solubility, n</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>The content of PZQ, % of theoretically</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>pH</i></b></th> </tr> </thead> <tbody> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Initial PZQ</td> <td align="center" valign="top" rowspan="1" colspan="1">0.234</td> <td align="center" valign="top" rowspan="1" colspan="1">-</td> <td align="center" valign="top" rowspan="1" colspan="1" /> <td align="center" valign="top" rowspan="1" colspan="1">7.2</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">PZQ/Na<sub>2</sub>GA 1/10 physical mixture</td> <td align="center" valign="top" rowspan="1" colspan="1">0,566</td> <td align="center" valign="top" rowspan="1" colspan="1">1.42</td> <td align="center" valign="top" rowspan="1" colspan="1">100</td> <td align="center" valign="top" rowspan="1" colspan="1">5.9</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">PZQ/Na<sub>2</sub>GA 1/5 м/ch</td> <td align="center" valign="top" rowspan="1" colspan="1">0.557</td> <td align="center" valign="top" rowspan="1" colspan="1">1.94</td> <td align="center" valign="top" rowspan="1" colspan="1">99.9</td> <td align="center" valign="top" rowspan="1" colspan="1">5.8</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">PZQ/Na<sub>2</sub>GA1/10 м/ch</td> <td align="center" valign="top" rowspan="1" colspan="1">0.687</td> <td align="center" valign="top" rowspan="1" colspan="1">2.94</td> <td align="center" valign="top" rowspan="1" colspan="1">99.6</td> <td align="center" valign="top" rowspan="1" colspan="1">6.0</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">PZQ/Na<sub>2</sub>GA1/20 м/ch</td> <td align="center" valign="top" rowspan="1" colspan="1">0.817</td> <td align="center" valign="top" rowspan="1" colspan="1">3.49</td> <td align="center" valign="top" rowspan="1" colspan="1">100.0</td> <td align="center" valign="top" rowspan="1" colspan="1">6.2</td> </tr> </tbody> </table> </div> <p>The phase diagrams of the solubility of PZQ from the compositions at different temperatures (<a href="#F4">Fig. 4</a>, <a href="#T2">Table 2</a>) were evaluated to prove intermolecular interactions in the aqueous solutions of PZQ with Na<sub>2</sub>GA and to estimate the stoichiometric and thermodynamic parameters of the inclusion of PZQ molecules into GA micelles. The resulting diagrams correspond to А<sub>L</sub>-type, which implies the formation of a complex with the stoichiometric ratio PZQ/Na<sub>2</sub>GA micelle 1/1.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 4:</span></a></div>   <p>Phase diagrams of the solubility of PZQ/Na<sub>2</sub>GA 1/10 (mass) compositions in aqueous solutions at different temperatures</p>   </div> <div class="table-wrap_UNKNOWN" id="T2" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 2:</span> <p>Thermodynamic parameters of the inclusion of PZQ molecules into micelles in Na<sub>2</sub>GA solution (mean±SE, n=3)</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" valign="top" rowspan="1" colspan="1"><b><i>T, °C</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>K, M<sup>−1</sup></i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>ΔG, kJ/mol</i></b></th> </tr> </thead> <tbody> <tr> <td align="left" valign="top" rowspan="1" colspan="1">+30</td> <td align="center" valign="top" rowspan="1" colspan="1">23.7±0.6</td> <td align="center" valign="top" rowspan="1" colspan="1">−8.0±0.1</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">+37</td> <td align="center" valign="top" rowspan="1" colspan="1">18.6±0.4</td> <td align="center" valign="top" rowspan="1" colspan="1">−7.5±0.1</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">+42</td> <td align="center" valign="top" rowspan="1" colspan="1">17.8±0.3</td> <td align="center" valign="top" rowspan="1" colspan="1">−7.6±0.1</td> </tr> </tbody> </table> </div> <p>The results of the measurement of trans-membrane transfer are shown in <a href="#F5">Fig. 5</a>. Evidently the rate of diffusion of PZQ molecules from its composition with Na<sub>2</sub>GA is much higher than that for initial PZQ substance. A substantial nearly 2-fold (for experiment duration 1 h) acceleration of transmembrane transfer from the solution of the complex was observed.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 5:</span></a></div>   <p>Membrane permeability of praziquantel. 1 – initial PZQ, 2 - PZQ/Na<sub>2</sub>GA 1/10</p>   </div> <p>The sample selected on the basis of the best physicochemical properties – the supramolecular complex of PZQ with Na<sub>2</sub>GA (1:10) was tested on the anthelmintic efficacy on the laboratory model of <i>H. nana</i> infection of mice and <i>M. expansa</i> infection of sheep.</p> <p>This study demonstrated 100 % efficacy of supramolecular complex of PZQ at the dose of 3 mg/kg (<a href="#T3">Table 3</a>) in <i>H. nana</i> infection of mice while the unmodified PZQ showed 27.19 % efficacy. At necropsy, 10 adults of <i>H. nana</i> were found in the small intestine of mice of control group indicating the presence of an established infection. Statistically all the treatment groups had significantly fewer number of <i>H. nana</i> (<i>P</i> &amp;lt; 0.001) compared with the control group. Thus, on average, 0.032 and 0.264 <i>H. nana</i> (geometric mean) were detected in the small intestines of mice after administration of supramolecular complex of PZQ at doses of 2.0 and 1.0 mg/kg respectively. The PZQ:Na<sub>2</sub>GA1/10 physical mixture revealed no anthelmintic efficacy.</p> <div class="table-wrap_UNKNOWN" id="T3" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 3:</span> <p><i>Hymenolepis nana</i> geometric counts, efficacy and statistical significance for treatment group (n = 10)</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" valign="top" rowspan="1" colspan="1"><b><i>Group of animals</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Supramolecular complex and its composition</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Dose, mg of active substance/kg of body weight</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Geometric mean of worms</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Efficacy<a href="#TFN1"><sup>a</sup></a> (%)</i></b></th> <th align="center" valign="middle" rowspan="1" colspan="1"><b><i>P-Value</i></b></th> </tr> </thead> <tbody> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Control</td> <td align="center" valign="top" rowspan="1" colspan="1">Placebo</td> <td align="center" valign="top" rowspan="1" colspan="1">–</td> <td align="center" valign="top" rowspan="1" colspan="1">24.423</td> <td align="center" valign="top" rowspan="1" colspan="1">NA</td> <td align="center" valign="top" rowspan="1" colspan="1">NA</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Treatment</td> <td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td> <td align="center" valign="top" rowspan="1" colspan="1">3.0</td> <td align="center" valign="top" rowspan="1" colspan="1">0</td> <td align="center" valign="top" rowspan="1" colspan="1">100</td> <td align="center" valign="top" rowspan="1" colspan="1">&amp;lt; 0.0001<a href="#TFN2"><sup>*</sup></a></td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Treatment</td> <td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td> <td align="center" valign="top" rowspan="1" colspan="1">2.0</td> <td align="center" valign="top" rowspan="1" colspan="1">0.032</td> <td align="center" valign="top" rowspan="1" colspan="1">99.99</td> <td align="center" valign="top" rowspan="1" colspan="1">&amp;lt; 0.0001<a href="#TFN2"><sup>*</sup></a></td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Treatment</td> <td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td> <td align="center" valign="top" rowspan="1" colspan="1">1.0</td> <td align="center" valign="top" rowspan="1" colspan="1">0.264</td> <td align="center" valign="top" rowspan="1" colspan="1">98.92</td> <td align="center" valign="top" rowspan="1" colspan="1">&amp;lt; 0.001<a href="#TFN2"><sup>*</sup></a></td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Treatment</td> <td align="center" valign="top" rowspan="1" colspan="1">PZQ substance</td> <td align="center" valign="top" rowspan="1" colspan="1">1.0</td> <td align="center" valign="top" rowspan="1" colspan="1">17.783</td> <td align="center" valign="top" rowspan="1" colspan="1">27.19</td> <td align="center" valign="top" rowspan="1" colspan="1">&amp;gt;0.05<a href="#TFN2"><sup>*</sup></a></td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Treatment</td> <td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA1/10 physical mixture</td> <td align="center" valign="top" rowspan="1" colspan="1">2.0</td> <td align="center" valign="top" rowspan="1" colspan="1">16.5</td> <td align="center" valign="top" rowspan="1" colspan="1">32.44</td> <td align="center" valign="top" rowspan="1" colspan="1">&amp;gt;0.05<a href="#TFN2"><sup>*</sup></a></td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">a</span><p>Percent efficacy based on geometric means</p> </div> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">*</span><p>Statistically significant at <i>P</i> ≤ 0.05 when geometric means were compared to placebo</p> </div> </div> </div> <p>The study showed 100 % efficacy of supra-molecular complex of PZQ against <i>M. expansa</i> infection of sheep at the dose of 3.0 mg/kg of b/w (<a href="#T4">Table 4</a>). Worms of <i>M. expansa</i> were found in the small intestine of sheep after administration of supramolecular complex of PZQ at doses of 2.0 and 1.0 mg/kg of b/w in the amount of 0.003 and 0.064 parasites per animal. The efficacy was 99.91 and 98.18 % respectively based on the geometric mean counts. At necropsy sheep of all the treatment groups had significantly fewer <i>M. expansa</i> worms (<i>P</i>&amp;lt;0.0001) compared with the control group. The unmodified PZQ showed 36.64 % efficacy against <i>M. expansa</i> infection at the dose of 1 mg/kg.</p> <div class="table-wrap_UNKNOWN" id="T4" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 4:</span> <p><i>Moniesia expansa</i> geometric counts, efficacy and statistical significance for treatment group</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" valign="top" rowspan="1" colspan="1"><b><i>Group of animals</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Supramolecular complex and its composition</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Dose, mg of active substance/kg of body weight</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Number of sheep in group</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Geometric mean of worms</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>Efficacy<a href="#TFN3"><sup>a</sup></a> (%)</i></b></th> <th align="center" valign="top" rowspan="1" colspan="1"><b><i>P-Value</i></b></th> </tr> </thead> <tbody> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Control</td> <td align="center" valign="top" rowspan="1" colspan="1">Placebo</td> <td align="center" valign="top" rowspan="1" colspan="1">–</td> <td align="center" valign="top" rowspan="1" colspan="1">10</td> <td align="center" valign="top" rowspan="1" colspan="1">3.524</td> <td align="center" valign="top" rowspan="1" colspan="1">NA</td> <td align="center" valign="top" rowspan="1" colspan="1">NA</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Treatment</td> <td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td> <td align="center" valign="top" rowspan="1" colspan="1">3.0</td> <td align="center" valign="top" rowspan="1" colspan="1">10</td> <td align="center" valign="top" rowspan="1" colspan="1">0</td> <td align="center" valign="top" rowspan="1" colspan="1">100</td> <td align="center" valign="top" rowspan="1" colspan="1">&amp;lt; 0.0001<a href="#TFN4"><sup>*</sup></a></td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Treatment</td> <td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td> <td align="center" valign="top" rowspan="1" colspan="1">2.0</td> <td align="center" valign="top" rowspan="1" colspan="1">11</td> <td align="center" valign="top" rowspan="1" colspan="1">0.003</td> <td align="center" valign="top" rowspan="1" colspan="1">99.91</td> <td align="center" valign="top" rowspan="1" colspan="1">&amp;lt; 0.001<a href="#TFN4"><sup>*</sup></a></td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Treatment</td> <td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td> <td align="center" valign="top" rowspan="1" colspan="1">1.0</td> <td align="center" valign="top" rowspan="1" colspan="1">12</td> <td align="center" valign="top" rowspan="1" colspan="1">0.064</td> <td align="center" valign="top" rowspan="1" colspan="1">98.18</td> <td align="center" valign="top" rowspan="1" colspan="1">&amp;lt; 0.001<a href="#TFN4"><sup>*</sup></a></td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1">Treatment</td> <td align="center" valign="top" rowspan="1" colspan="1">PZQ substance</td> <td align="center" valign="top" rowspan="1" colspan="1">1.0</td> <td align="center" valign="top" rowspan="1" colspan="1">11</td> <td align="center" valign="top" rowspan="1" colspan="1">2.233</td> <td align="center" valign="top" rowspan="1" colspan="1">36.64</td> <td align="center" valign="top" rowspan="1" colspan="1">&amp;gt;0.05<a href="#TFN4"><sup>*</sup></a></td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">a</span><p>Percent efficacy based on geometric means</p> </div> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">*</span><p>Statistically significant at <i>P</i> ≤ 0.05 when geometric means were compared to placebo</p> </div> </div> </div> <p>On average, 3.52 <i>M. expansa</i> worms were found in the small intestine of sheep in the control group that demonstrated an established infection of sheep in current study.</p> </div> <div class="discussion" title="discussion"> <div class="title" tagx="title" title="title">
Discussion</div> <p>PZQ is the main drug for the treatment of humans and animals’ opisthorchiasis, clonorchosis, schistosomiasis, echinococcosis, cysticercosis, hymenolepiasis and other intestinal cestodosis (<a href="#B2">2</a>, <a href="#B24">24</a>). Insufficient efficacy of PZQ in some helminthosis, including schistosomiasis, opisthorchiasis is caused by its low solubility and rapid metabolism in the liver with forming inactive compounds (<a href="#B25">25</a>, <a href="#B26">26</a>). In this regard, the drug is used in an increased dose and in several ways to achieve maximum efficacy. Polyvinylpyrrolidone (<a href="#B27">27</a>), polysaccharides (<a href="#B11">11</a>,<a href="#B15">15</a>), GA, Na<sub>2</sub>GA (<a href="#B6">6</a>), are also used as a means for targeted delivery of anthelmintics. GA is able to form self-associates - micelles in aqueous solution because of the amphiphilic structure (<a href="#B7">7</a>). In this case, poorly soluble molecules of medicinal substances are included in the structures of micelles and thereby increase their concentration in solution. The best solution in this respect is Na<sub>2</sub>GA as a "vehicle" (<a href="#B28">28</a>).</p> <p>Our studies of physicochemical properties confirmed an increase in the solubility of the supramolecular complex of PZQ with Na<sub>2</sub>GA in comparison with basic PZQ and the loss of its crystallinity up to the formation of amorphous phases. Solubility changed depending on the mass ratio of the components, the method of obtaining the compositions and time of mechanochemical processing. Since an increase in the proportion of PZQ leads to decrease in solubility and an increase in the proportion of Na<sub>2</sub>GA overloads the dosage form for oral administration. Therefore, 1/10 mass ratio of PZQ/Na<sub>2</sub>GA was optimal for further studies and had a good solubility index. Thermal and X-ray analyses showed that reflexes and melting peaks that are characteristic of the initial crystalline phase of PZQ have disappeared after mechanochemical processing. It can be assumed that molecules of PZQ are distributed in the amorphous Na<sub>2</sub>GA matrix, thereby greatly facilitating the formation of the guest-host system, where the guest is the molecules of PZQ and the host is the Na<sub>2</sub>GA carrier. This distribution significantly changes the properties of the drug and facilitates its release and transfer through biological membranes (<a href="#B29">29</a>). The micrographs obtained by electronic scanning microscopy revealed that reduction of the size of particles of supramolecular complex of PZQ. The occurrence of the intermolecular interaction of PZQ with the micelles of GA in solution was demonstrated by means of phase solubility. Investigation of the permeability of PZQ through the artificial membrane by PAMPA assay demonstrated that the rate of PZQ molecule diffusion from its composition with Na<sub>2</sub>GA is much higher than that of initial PZQ.</p> <p>In the present study the efficacy of the supramolecular complex of PZQ with Na<sub>2</sub>GA was three times higher than the efficacy of the substance of PZQ in the experiment carried out on white mice experimentally infected with <i>H. nana</i> and sheep naturally infected with moniezia at the dose of 1 mg/kg of b/w.</p> </div> <div class="conclusion" title="conclusion"> <div class="title" tagx="title" title="title">
Conclusion</div> <p>Joint mechanochemical processing of the PZQ substance and Na<sub>2</sub>GA led to reduction of particle sizes, increased solubility, amorphization of substance, incorporating it with micelles of GA and high anthelmintic efficacy in reduced dose. The supramolecular complex of praziquantel was found to be a perspective anthelminthic with enhanced pharmacological activity that needs further research.</p> </div> <div class="ethicalconsiderations" title="sec"> <div class="title" tagx="title" title="title">
Ethical considerations</div> <p>Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.</p> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>This research was carried out within the State Assignment to ISSCM SB RAS (project 0301-2019-0008) and was supported by the Ministry of Science and Higher Education of the Russian Federation. The authors would like to thank the technical support of specialists of LTD Agro resource of Samarskaya region.</p> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-COI-statement" title="COI-statement"> <p><b>Conflict of interest</b></p> <p>The authors declare that there is no conflict of interest.</p> </div> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="B1" /><span class="label" tagx="label" title="label">1.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sergiev</span><span class="given-names" tagx="given-names" title="given-names">VP.</span></span></span><span class="source" tagx="source" title="source">Atlas of clinical parasitology and tropical medicine</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Moscow</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Author’s Academy</span>; <span class="year" tagx="year" title="year">2010</span>.</span></li> <li tag="ref"><a name="B2" /><span class="label" tagx="label" title="label">2.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Campbell</span><span class="given-names" tagx="given-names" title="given-names">WC</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rew</span><span class="given-names" tagx="given-names" title="given-names">RS.</span></span></span><span class="source" tagx="source" title="source">Chemotherapy of parasitic diseases</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">New York and London</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Plenum Press</span>; <span class="year" tagx="year" title="year">1986</span>.</span></li> <li tag="ref"><a name="B3" /><span class="label" tagx="label" title="label">3.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thomas</span><span class="given-names" tagx="given-names" title="given-names">H</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gönnert</span><span class="given-names" tagx="given-names" title="given-names">R</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pohlke</span><span class="given-names" tagx="given-names" title="given-names">R</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A new compound against adult tapeworms</span>. <span class="conf-name" tagx="conf-name" title="conf-name">Thessoloniki: Proc of the 7th Int Conf of the World Ass for the Advancement of Vet Parasitol</span>; <span class="year" tagx="year" title="year">1975</span>.</span></li> <li tag="ref"><a name="B4" /><span class="label" tagx="label" title="label">4.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Andrews</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thomas</span><span class="given-names" tagx="given-names" title="given-names">H</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pohlke</span><span class="given-names" tagx="given-names" title="given-names">R</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Praziquantel</span>. <span class="source" tagx="source" title="source">Med Res Rev</span>. <span class="year" tagx="year" title="year">1983</span>; <span class="volume" tagx="volume" title="volume">3</span>(<span class="issue" tagx="issue" title="issue">2</span>):<span class="fpage" tagx="fpage" title="fpage">147</span>–<span class="lpage" tagx="lpage" title="lpage">200</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/6408323">6408323</a></span></span></li> <li tag="ref"><a name="B5" /><span class="label" tagx="label" title="label">5.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Riviere</span><span class="given-names" tagx="given-names" title="given-names">JE</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Papich</span><span class="given-names" tagx="given-names" title="given-names">MG.</span></span></span><span class="source" tagx="source" title="source">Veterinary pharmacology &amp;amp; Therapeutics</span>. <span class="edition" tagx="edition" title="edition">9th ed</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Hoboken</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Willey Blackwell</span>; <span class="year" tagx="year" title="year">2009</span>.</span></li> <li tag="ref"><a name="B6" /><span class="label" tagx="label" title="label">6.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Graebin</span><span class="given-names" tagx="given-names" title="given-names">CS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Merillon</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramawat</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The pharmacological activities of glycyrrhizinic acid ("glycyrrhizin") and glycyrrhetinic acid</span>. In: editors. Sweeteners. <span class="source" tagx="source" title="source">Nature Public Health Emergency Collectio</span>. <span class="year" tagx="year" title="year">2017</span> p. <span class="fpage" tagx="fpage" title="fpage">245</span>–<span class="lpage" tagx="lpage" title="lpage">261</span>.</span></li> <li tag="ref"><a name="B7" /><span class="label" tagx="label" title="label">7.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dushkin</span><span class="given-names" tagx="given-names" title="given-names">AV</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tolstikova</span><span class="given-names" tagx="given-names" title="given-names">TG</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khvostov</span><span class="given-names" tagx="given-names" title="given-names">MV</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Complexes of polysaccharides and glycyrrhizic acid with drug molecules. Mechano-chemical synthesis and pharmacological activity</span>. In: <span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Karunaratn</span><span class="given-names" tagx="given-names" title="given-names">DN</span></span></span>, editor. <span class="source" tagx="source" title="source">The complex world of polysaccharides</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Rijeka</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">InTech</span>; <span class="year" tagx="year" title="year">2012</span> p. <span class="fpage" tagx="fpage" title="fpage">573</span>–<span class="lpage" tagx="lpage" title="lpage">602</span>.</span></li> <li tag="ref"><a name="B8" /><span class="label" tagx="label" title="label">8.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Habriev</span><span class="given-names" tagx="given-names" title="given-names">RU.</span></span></span><span class="source" tagx="source" title="source">The guidance to experimental (preclinical) studying of new pharmacological substances</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Moscow</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Publishing House Medicine</span>; <span class="year" tagx="year" title="year">2005</span>.</span></li> <li tag="ref"><a name="B9" /><span class="label" tagx="label" title="label">9.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="mixed-article-title" title="mixed-article-title">The order of the Ministry of Health of the Russian Federation, April 1st, 2016, No. 200</span>. On the approval of the rules of good clinical practice.</span></li> <li tag="ref"><a name="B10" /><span class="label" tagx="label" title="label">10.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="mixed-article-title" title="mixed-article-title">European Convention for the Protection of Vertebrate Animals used for experimental and other scientific purposes</span>. Strasbourg, <span class="year" tagx="year" title="year">1986</span>.</span></li> <li tag="ref"><a name="B11" /><span class="label" tagx="label" title="label">11.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meteleva</span><span class="given-names" tagx="given-names" title="given-names">ES</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chistyachenko</span><span class="given-names" tagx="given-names" title="given-names">YS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Suntsova</span><span class="given-names" tagx="given-names" title="given-names">LP</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Physicochemical properties and anti-opisthorchosis effect of mechanochemically synthesized solid compositions of praziquantel with glycyrrhizic acid disodium salt</span>. <span class="source" tagx="source" title="source">Dokl Biochem Biophys</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">481</span>:<span class="fpage" tagx="fpage" title="fpage">228</span>–<span class="lpage" tagx="lpage" title="lpage">31</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30168067">30168067</a></span></span></li> <li tag="ref"><a name="B12" /><span class="label" tagx="label" title="label">12.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Polyakov</span><span class="given-names" tagx="given-names" title="given-names">NE</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chistyachenko</span><span class="given-names" tagx="given-names" title="given-names">YS</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry</span>. <span class="source" tagx="source" title="source">Drug Deliv</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">25</span>(<span class="issue" tagx="issue" title="issue">1</span>):<span class="fpage" tagx="fpage" title="fpage">198</span>–<span class="lpage" tagx="lpage" title="lpage">209</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29302995">29302995</a></span></span></li> <li tag="ref"><a name="B13" /><span class="label" tagx="label" title="label">13.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Higuchi</span><span class="given-names" tagx="given-names" title="given-names">TA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Connors</span><span class="given-names" tagx="given-names" title="given-names">KA.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Phase solubility techniques</span>. In: <span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reilley</span><span class="given-names" tagx="given-names" title="given-names">CN</span></span></span>, editor. <span class="source" tagx="source" title="source">Advances in Analytical Chemistry and Instrumentation</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">New York</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Wiley-Interscience</span>; <span class="year" tagx="year" title="year">1965</span> p. <span class="fpage" tagx="fpage" title="fpage">117</span>–<span class="lpage" tagx="lpage" title="lpage">212</span>.</span></li> <li tag="ref"><a name="B14" /><span class="label" tagx="label" title="label">14.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kansy</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Senner</span><span class="given-names" tagx="given-names" title="given-names">F</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gubernator</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Physico-chemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span>. <span class="source" tagx="source" title="source">J Med Chem</span>. <span class="year" tagx="year" title="year">1998</span>; <span class="volume" tagx="volume" title="volume">41</span>(<span class="issue" tagx="issue" title="issue">7</span>):<span class="fpage" tagx="fpage" title="fpage">1007</span>–<span class="lpage" tagx="lpage" title="lpage">10</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9544199">9544199</a></span></span></li> <li tag="ref"><a name="B15" /><span class="label" tagx="label" title="label">15.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khalikov</span><span class="given-names" tagx="given-names" title="given-names">SS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chistyachenko</span><span class="given-names" tagx="given-names" title="given-names">YS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dushkin</span><span class="given-names" tagx="given-names" title="given-names">AV</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Development of anthelmintic drugs of increased efficiency on the basis of intermolecular complexes of active substances with water-soluble polymers including polysaccharides</span>. <span class="source" tagx="source" title="source">J Chem Sustain Dev</span>. <span class="year" tagx="year" title="year">2015</span>; <span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">567</span>–<span class="lpage" tagx="lpage" title="lpage">77</span>.</span></li> <li tag="ref"><a name="B16" /><span class="label" tagx="label" title="label">16.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Arkhipov</span><span class="given-names" tagx="given-names" title="given-names">IA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sadov</span><span class="given-names" tagx="given-names" title="given-names">KM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Limova</span><span class="given-names" tagx="given-names" title="given-names">YV</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">The efficacy of the supramolecular complexes of niclosamide obtained by mechanochemical technology and targeted delivery against cestode infection of animals</span>. <span class="source" tagx="source" title="source">Vet Parasitol</span>. <span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">246</span>:<span class="fpage" tagx="fpage" title="fpage">25</span>–<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28969776">28969776</a></span></span></li> <li tag="ref"><a name="B17" /><span class="label" tagx="label" title="label">17.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Arkhipov</span><span class="given-names" tagx="given-names" title="given-names">IA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Engasheva</span><span class="given-names" tagx="given-names" title="given-names">ES</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khalikov</span><span class="given-names" tagx="given-names" title="given-names">SS</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Innovative technology for preparing of anthelmintic drugs</span>. <span class="source" tagx="source" title="source">Veterinary</span>. <span class="year" tagx="year" title="year">2016</span>; <span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">3</span>–<span class="lpage" tagx="lpage" title="lpage">10</span>.</span></li> <li tag="ref"><a name="B18" /><span class="label" tagx="label" title="label">18.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="mixed-article-title" title="mixed-article-title">The order of the Ministry of Health of the USSR, October 10th, 1983, No. 1179</span> "On approval of feed standards for laboratory animals in health facilities".</span></li> <li tag="ref"><a name="B19" /><span class="label" tagx="label" title="label">19.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Astafyev</span><span class="given-names" tagx="given-names" title="given-names">BA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yarotsky</span><span class="given-names" tagx="given-names" title="given-names">LS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lebedeva</span><span class="given-names" tagx="given-names" title="given-names">MN.</span></span></span><span class="source" tagx="source" title="source">Experimental models of parasites in biology and medicine</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Moscow</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Nauka</span>; <span class="year" tagx="year" title="year">1989</span>.</span></li> <li tag="ref"><a name="B20" /><span class="label" tagx="label" title="label">20.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalashnikov</span><span class="given-names" tagx="given-names" title="given-names">AP</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fisin</span><span class="given-names" tagx="given-names" title="given-names">VF</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shcheglova</span><span class="given-names" tagx="given-names" title="given-names">VV</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="source" tagx="source" title="source">Norms and rations of feeding livestock</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Moscow</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Rosselkhozakademiya</span>; <span class="year" tagx="year" title="year">2003</span>.</span></li> <li tag="ref"><a name="B21" /><span class="label" tagx="label" title="label">21.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="collab'">collab: Ministry of Agriculture, Fisheries and Food.</span></span><span class="source" tagx="source" title="source">Manual of veterinary parasitological laboratory techniques</span>. Reference Book 418. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">London</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Her Majesty’s Stationery Office</span>; <span class="year" tagx="year" title="year">1986</span>.</span></li> <li tag="ref"><a name="B22" /><span class="label" tagx="label" title="label">22.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wood</span><span class="given-names" tagx="given-names" title="given-names">IB</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Amaral</span><span class="given-names" tagx="given-names" title="given-names">NK</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bairden</span><span class="given-names" tagx="given-names" title="given-names">K</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">World Association for the Advancement of Veterinary Parasitology (WAAVP) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine)</span>. <span class="source" tagx="source" title="source">Vet Parasitol</span>. <span class="year" tagx="year" title="year">1995</span>; <span class="volume" tagx="volume" title="volume">58</span>(<span class="issue" tagx="issue" title="issue">3</span>):<span class="fpage" tagx="fpage" title="fpage">181</span>–<span class="lpage" tagx="lpage" title="lpage">213</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/7571325">7571325</a></span></span></li> <li tag="ref"><a name="B23" /><span class="label" tagx="label" title="label">23.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ivashkin</span><span class="given-names" tagx="given-names" title="given-names">VM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oripov</span><span class="given-names" tagx="given-names" title="given-names">AO</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sonin</span><span class="given-names" tagx="given-names" title="given-names">MD.</span></span></span><span class="source" tagx="source" title="source">The determinant of helminthes of small cattle</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Moscow</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Nauka</span>; <span class="year" tagx="year" title="year">1989</span>.</span></li> <li tag="ref"><a name="B24" /><span class="label" tagx="label" title="label">24.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Arkhipov</span><span class="given-names" tagx="given-names" title="given-names">IA.</span></span></span><span class="source" tagx="source" title="source">Anthelmintics: pharmacology and application</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Moscow</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Rosselkhozakademiya</span>; <span class="year" tagx="year" title="year">2009</span>.</span></li> <li tag="ref"><a name="B25" /><span class="label" tagx="label" title="label">25.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Linderberg</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kopp</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dressman</span><span class="given-names" tagx="given-names" title="given-names">JB.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system</span>. <span class="source" tagx="source" title="source">Eur J Pharm Biopharm</span>. <span class="year" tagx="year" title="year">2004</span>; <span class="volume" tagx="volume" title="volume">58</span>(<span class="issue" tagx="issue" title="issue">2</span>):<span class="fpage" tagx="fpage" title="fpage">265</span>–<span class="lpage" tagx="lpage" title="lpage">78</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15296954">15296954</a></span></span></li> <li tag="ref"><a name="B26" /><span class="label" tagx="label" title="label">26.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dayan</span><span class="given-names" tagx="given-names" title="given-names">AD.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics</span>. <span class="source" tagx="source" title="source">Acta Trop</span>. <span class="year" tagx="year" title="year">2003</span>; <span class="volume" tagx="volume" title="volume">86</span>(<span class="issue" tagx="issue" title="issue">2–3</span>):<span class="fpage" tagx="fpage" title="fpage">141</span>–<span class="lpage" tagx="lpage" title="lpage">59</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12745134">12745134</a></span></span></li> <li tag="ref"><a name="B27" /><span class="label" tagx="label" title="label">27.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Skira</span><span class="given-names" tagx="given-names" title="given-names">VN</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dushkin</span><span class="given-names" tagx="given-names" title="given-names">AV</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chistyachenko</span><span class="given-names" tagx="given-names" title="given-names">YS</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Efficacy of the supramolecular complex of fenbendazole in nematodiasis of sheep</span>. <span class="source" tagx="source" title="source">Rus Parasitol J</span>. <span class="year" tagx="year" title="year">2016</span>; <span class="fpage" tagx="fpage" title="fpage">76</span>–<span class="lpage" tagx="lpage" title="lpage">81</span>.</span></li> <li tag="ref"><a name="B28" /><span class="label" tagx="label" title="label">28.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kong</span><span class="given-names" tagx="given-names" title="given-names">R</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">X</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meteleva</span><span class="given-names" tagx="given-names" title="given-names">ES</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Enhanced solubility and bioavailability of simvastatin mechanochemically obtained complexes</span>. <span class="source" tagx="source" title="source">Int J Pharm</span>. <span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">534</span>(<span class="issue" tagx="issue" title="issue">1–2</span>):<span class="fpage" tagx="fpage" title="fpage">108</span>–<span class="lpage" tagx="lpage" title="lpage">118</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28993167">28993167</a></span></span></li> <li tag="ref"><a name="B29" /><span class="label" tagx="label" title="label">29.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Selyutina</span><span class="given-names" tagx="given-names" title="given-names">OY</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Apanasenko</span><span class="given-names" tagx="given-names" title="given-names">IE</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Polyakov</span><span class="given-names" tagx="given-names" title="given-names">NE.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Membrane-modifying activity of glycyrrhizic acid</span>. <span class="source" tagx="source" title="source">Russ Chem Bull</span>. <span class="year" tagx="year" title="year">2015</span>; <span class="volume" tagx="volume" title="volume">64</span>:<span class="fpage" tagx="fpage" title="fpage">1555</span>–<span class="lpage" tagx="lpage" title="lpage">1559</span>.</span></li> </ul> </div> </div>  </body></html>